Enhanced cancer immunotherapy via synergistic action of NO-Donor nanoparticles (NanoARG) and PD-1 antibody cancer immunotherapy immune checkpoint inhibitor (PD-1 antibody) nanoparticle-based nitric oxide donor poly(L-arginine)-based polymer micelles synergistic anti-tumor effect tumor-associated macrophages
